FindTrial
Sign In

To compare the effect of Utrogestan and Duphaston in normalovulatory women undergoing IVF in the follicular primed-progesterone ovarian stimulation protocol

To compare the effect of Utrogestan and Duphaston in normalovulatory women undergoing IVF in the follicular primed-progesterone ovarian stimulation protocol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007265
Enrollment
Unknown
Registered
2015-10-23
Start date
2015-10-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Utrogestan group: Utrogestan
Duphaston group: Duphaston

Sponsors

Shanghai Ninth Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: infertility women, aged 20-40 years, normal mentrual cycle(23-35 days), tubal or male factors, basal FSH<10IU/L, antral follicle counts more than 4.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
the number of oocytes retrieved;—

Secondary

MeasureTime frame
the number of viable embryos;incidence of premature LH surge;LH value;pregnancy rate;—

Contacts

Public ContactYonglun Fu
fuyonglunivf@163.com+86 13917547302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 9, 2026